New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Shape
Ocular Therapeutix, Inc.
OCUL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 10 Mar 2025

1B

Biotechnology

Next Earning date - 10 Mar 2025

8.76USD
Shape0.02 ( 0.23%)
Market Closed (as of Jan 03, 21:00 EDT)
favorite-chart

Relative Strenght

87
favorite-chart

Volume Buzz

-49%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

26%

Quote Panel

Shape
Updated January 4, 2025
1W 4.91 % 1M -4.58 % 3M -7.59 % 1Y 99.09 %

Key Metrics

Shape
  • Market Cap

    1.38B


  • Shares Outstanding

    157.22M


  • Share in Float

    135.64M


  • Dividende

    0


  • Earning Date

    10 Mar 2025


  • Price Target

    8.76


  • Average Volume

    1.04M


  • Beta

    1.256


  • Range

    3.76-11.775


  • Industry

    Biotechnology


  • Website

    https://www.ocutx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

22.44x

P/S Ratio

4.16x

P/B Ratio

0.2

Debt/Equity

-284.0%

Net Margin

$-1.3

EPS

How OCUL compares to sector?

P/E Ratio

Relative Strength

Shape

OCUL

Sector

90 days

Showing graph for last 90 days.

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Scholar Rock Holding Corporation

99

2.68%

Tevogen Bio Holdings Inc.

98

10.89%

Summit Therapeutics Inc.

98

1.96%

NewAmsterdam Pharma Company N.V.

97

1.58%

Anavex Life Sciences Corp.

96

3.69%

Forecast

Shape

$72M

Shape368%

2025-Revenue

$1.07

Shape-385%

2025-EPS

$72M

Shape-124%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Cowen & Co.

upgrade

Previous: Hold

2024-06-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.24
vs -0.23

Q1.23

arrow
arrow

N/A

-0.31
vs -0.22

Q2.23

arrow
arrow

N/A

-0.27
vs -0.28

Q3.23

arrow
arrow

N/A

-0.51
vs -0.30

Q4.23

arrow
arrow

N/A

-0.28
vs -0.24

Q1.24

arrow
arrow

N/A

-0.24
vs -0.31

Q2.24

arrow
arrow

N/A

-0.24
vs -0.27

Q3.24

arrow
arrow

N/A

-0.26
vs -0.51

Q4.24

arrow
arrow

N/A

-0.25
vs -0.28

Q1.25

arrow
arrow

N/A

-0.26
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+14%

14.1M  vs 12.3M

Q1.23

arrow
arrow

+1%

13.4M  vs 13.2M

Q2.23

arrow
arrow

+24%

15.2M  vs 12.3M

Q3.23

arrow
arrow

+25%

14.9M  vs 12M

Q4.23

arrow
arrow

+5%

14.8M  vs 14.1M

Q1.24

arrow
arrow

+10%

14.7M  vs 13.4M

Q2.24

arrow
arrow

+8%

16.4M  vs 15.2M

Q3.24

arrow
arrow

+3%

15.4M  vs 14.9M

Q4.24

arrow
arrow

+16%

17.2M  vs 14.8M

Q1.25

arrow
arrow

+14%

16.8M  vs 14.7M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-33%

-0.33
vs -0.58

Q1.23

arrow
arrow

-375%

-3.75
vs -0.33

Q2.23

arrow
arrow

-670%

-6.70
vs -3.75

Q3.23

arrow
arrow

-7%

-0.07
vs -6.70

Q4.23

arrow
arrow

-32%

-0.32
vs -0.07

Q1.24

arrow
arrow

-16%

-0.16
vs -0.32

Q2.24

arrow
arrow

-12%

-0.12
vs -0.16

Q3.24

arrow
arrow

-10%

-0.10
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

122

122
vs 136

-10%

Q1.23

arrow
arrow

133

133
vs 122

9%

Q2.23

arrow
arrow

143

143
vs 133

8%

Q3.23

arrow
arrow

119

119
vs 143

-17%

Q4.23

arrow
arrow

123

123
vs 119

3%

Q1.24

arrow
arrow

153

153
vs 123

24%

Q2.24

arrow
arrow

152

152
vs 153

-1%

Q3.24

arrow
arrow

173

173
vs 152

14%

Earnings Growth

Latest News

OCUL

seekingalpha.com

12 hours ago